학술논문

Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma
Document Type
Article
Source
In Blood 10 November 2022 140(19):2024-2036
Subject
Clinical Trials and Observations
Lymphoid Neoplasia
Language
ISSN
0006-4971